| Financial Year |
March 31 2023 |
| Monetary Funds |
110,592,988.33 |
| Held-for-trading Financial Assets |
4,698,409.72 |
| Notes Receivable |
995,000.00 |
| Accounts Receivable |
788,962,218.26 |
| Advances to Suppliers |
66,867,814.73 |
| Other Receivables |
31,907,920.54 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
256,718,816.55 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
1,931,735.87 |
| Other Current Assets |
76,579,236.85 |
| Total Current Assets |
1,427,090,244.11 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
17,246,448.72 |
| Long-term Equity Investment |
8,709,790.14 |
| Investment Properties |
225,003,831.33 |
| Fixed Assetes |
889,413,962.85 |
| Under-construction Projects |
27,145,107.52 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
118,461,404.91 |
| R&D expenses |
6,479,953.01 |
| Goodwill |
211,001,851.93 |
| Long-Term Deferred and Prepaid Expenses |
92,069,879.75 |
| Deferred Income Tax Assets |
27,322,763.63 |
| Other Non-Current Assets |
27,724,931.98 |
| Sub-Total of Non-Current Assets |
2,040,558,398.11 |
| Total Assets |
3,467,648,642.22 |
| Short-Term Loans |
360,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
278,858,555.15 |
| Accounts Received In Advance |
3,699,971.10 |
| Employee Compensation Payable |
33,234,188.54 |
| Taxes Payable |
70,459,522.06 |
| Interest Payable |
-- |
| Dividend Payable |
13,090,181.62 |
| Other payables |
363,101,326.84 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
56,861,061.26 |
| Other Current Liabilities |
1,272,732.54 |
| Sub-Total of Current Liabilities |
1,238,347,976.24 |
| Long-term Loans |
155,750,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
11,915,973.36 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
3,851,268.73 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
543,717,469.52 |
| Total Liabilities |
1,782,065,445.76 |
| Paid-In Capital(Or Share Stock) |
753,126,982.00 |
| Capital Surplus |
1,576,028,798.22 |
| Surplus Reserve |
83,015,164.70 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-893,195,958.77 |
| Minority Stockholder's Interest |
194,040,353.57 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,491,542,842.89 |
| Owner's Equity（Stockholder's Equity） |
1,685,583,196.46 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,467,648,642.22 |
